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8.1  Introduction
Primary care computing in the UK has been presented as a national success story 
for health informatics development and use (Benson 2002a, b). Despite each UK 
nation having its own devolved National Health Service and developing its own 
systems, primary care health professionals in England, Northern Ireland, Wales 
and Scotland all use electronic patient records, on-screen prescribing decision 
support, and electronic prescription printing. Recently this has been augmented 
by the adoption of electronic transmission of prescriptions (ETP), with each 
devolved nation’s NHS developing their own version to meet local needs. The 
subject of this chapter is the solution adopted by England’s National Health 
Service (NHS), which takes the institutional form of the Electronic Prescription 
Service (EPS).
England’s EPS was designed to support the processing and management of 
increasing primary care prescription volumes, which have shown a consistent 
growth of around 5% a year for the last two decades. Currently, England’s 56 
million citizens receive over 1,000 million prescription items from NHS primary 
care services. Whilst the potential for electronic prescription transmission has 
been long recognised, the development and deployment of EPS as a national 
system has taken over 13 years (2003–2015). As of early 2016, deployment is 
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ongoing, although the service looks to be gaining widespread acceptance as it 
has now been installed in 98% of the 11,844 community pharmacies, and 78% of 
the 7,803 GP practices in England (Health and Social Care Information Centre 
2016).
In this chapter, we examine the making of EPS and the forces that shaped its 
present form and status. EPS has been assembled as an operational service from 
decades of technical development and pilot implementation efforts brought 
together within a specific project under the NHS National Programme for 
Information Technology (NPfIT) – the decade long centrally mandated initiative 
running from 2002 to 2013. It also drew heavily from (and at times changed) the 
established work practice in primary care. Our analysis adopts three interlinked 
temporal perspectives to trace the influence of existing systems, old and new infra-
structures and wider interests in the way EPS has been assembled. These are 
expressed as; (1) a causal past represented by history and the installed base, (2) a 
concurrent present of established practices and change programmes seeking to 
influence them, (3) desired futures as reflected in policy goals and visions. Thus 
EPS is assembled from its past, its present and its future(s). This process is traced 
out using three interwoven perspectives; the realization and negotiation of con-
straints found in the wider NHS context that limit change, as inertia arising from 
limited resources and weak incentive structures, and in a purposive fidelity to exist-
ing institutional culture, seen here most directly in the history, practices and ethos 
of the NHS (Fig. 8.1).
This chapter draws data from a commissioned evaluation of EPS (see Box on 
Methods and Data), reported in Cornford et al. (2014), although the analysis here 
is new. In particular we focus on how the EPS entering wide scale use today 
(2016) draws on extant technologies and installed bases of infrastructures, and 
how this relates to and reflects the practices and interests of multiple stakeholders. 
EPS draws from, and contributes to, the long history of UK health informatics 
(Fig. 8.2). This is a history characterised by incremental development and pilot 
deployments, recurring local and national initiatives, and successive policies 
looking for service transformation through technology. The history begins with 
the computerisation of hospital admissions and hospital pathology laboratories in 
the 1960s (Brennan 2005), and continues into the present with a promise of an 
Integrated Digital Care Record (NHS England 2013). This history is punctuated 
by occasional failures, for example with the Care Records Service (CRS) compo-
nent of the National Programme for Information Technology (Matheison 2011). 
Still, the NHS continues to pursue, with undimmed enthusiasm, the new frontiers 
of health informatics. Thus current informatics policy is focused on supporting a 
transformed service that embodies integrated patient-centred care, accountability 
in care provision, and the capture and curation of aggregated data for NHS man-
agement, research and the promotion of better health and healthcare (NHS 
England 2013).
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Fig. 8.1 The analytical model used
Methods and Data
This chapter draws from work conducted as part of the Evaluation of the 
Electronic Prescription Service in Primary Care, a project which ran from 
2008 to 2013 and was funded by the Connecting for Health Evaluation 
Programme (Cornford et al. 2014; Hibberd et al. 2012; Petrakaki et al. 2012; 
Lichtner et al. 2012). In writing this chapter we identified from the project 
data key exemplars of where the installed base, which can be thought of as a 
multi-layered set of socio-technical systems, based on Cornford et al. (1994), 
constrained or influenced the development of the service.
The evaluation encompassed both a historical analysis and an examination of 
the contemporary development of the service through interviews with key stake-
holders from the agencies and software companies developing the systems, end-
users in the form of patients, GPs and community pharmacists, as well as 
observations of practice. This data provided an understanding of the intent of the 
system, its operation in various settings, and examples of operational surprises 
which often revealed unforeseen influences of the installed base.
The EPS has undergone further development since the evaluation research 
ended. To reflect this we also examined contemporary public literature from 
the EPS delivery agency, the Health and Social Care Information Centre, and 
from practitioner organisations, such as the Pharmaceutical Services 
Negotiating Committee, an organisation that has been an influential stake-
holder in the development of the EPS.
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Fig. 8.2 Timeline of electronic prescription development in England
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8.2  Primary Care and Health Informatics in England
The NHS commissions and delivers healthcare at a population level, supporting the 
development of health informatics to help achieve its broader remit for care. Funding 
for the service is through both general taxation and the charging of capped co- 
payments for some services, including primary care prescriptions. It commissions 
care from both public and private healthcare facilities. The NHS has also developed 
an unenviable reputation for reorganization of its core management structures 
(Talbot-Smith and Pollock 2006). Current policy, following the Health and Social 
Care Act of 2012, places emphasis on devolution of decision-making, service com-
missioning and budgeting. This landscape might appear incompatible with national 
informatics programmes such as EPS, and indeed EPS did emerge from a different 
economic and political era, being conceived in 2003 as part of the National 
Programme for Information Technology (NPfIT) that sought to direct informatics 
initiatives from the centre (Takian and Cornford 2012).
From its foundation in 1948 primary care in the NHS has been delivered mostly 
by private sector providers (Talbot-Smith and Pollock 2006). A rough division can 
be drawn between those who diagnose, prescribe and refer on to secondary care, 
typically general practitioners (GPs) and those licensed to provide therapeutic aids 
and drugs to patients, typically community pharmacies in high street shops. Both 
constituencies represent private businesses providing services to NHS patients 
though local and national commissioning contracts.
The devolved structure of primary care presents a challenge to new informatics 
based initiatives, insofar as any new service requires that primary care providers 
adopt compatible systems that are themselves supplied through competitive private 
sector markets, and to assent to sharing of data with both other primary care service 
providers and NHS secondary use services (Cornford et al. 2014). Thus NHS pri-
mary care providers and their informatics contractors, can and do at times hesitate 
and resist when asked to deploy new services and systems. Provision and use of 
health informatics services also reflects, in most cases, espoused health policy 
visions and strategies and come with some associated incentives. Thus, in the case 
of EPS there is a policy vision of community pharmacy as a resource that can sup-
port prescribers and patients by undertaking a greater role in the management of 
drug therapies for patients with chronic illness.
8.2.1  Prescribing, Dispensing and Reimbursing  
Primary Care Drugs
The typical pattern of prescription management in primary care is for the general 
practitioner to issue a prescription and for a community pharmacist to dispense 
against this, as appropriate. This division was first enshrined in the 1911 National 
Insurance Act which removed from prescribers the right to provide therapeutic 
drugs as part of a single care package (Anderson 2006). This had the effect of 
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supporting an emerging pharmacy profession that gained greater and greater impor-
tance over the next 80 years as an ever-expanding catalogue of pre-packaged ready 
to use, experimentally proven drugs displaced the remedies traditionally com-
pounded by pharmacists (Wade 1993).
More recently, during the period from 1979 to 2013, the average number of pre-
scription items dispensed in primary care per capita each year has increased from 6 
to 19 (Government Statistical Service 1991; Comptroller and Auditor General 1992; 
Health and Social Care Information Centre 2015), with those over 60 years of age 
receiving on average over forty prescription items per year. Increasing life expec-
tancies and the associated increases in co-morbidities suggest that the prescribing 
and dispensing activities of primary care will become more central to care, more 
complex and could also have greater potential for harm (Banarjee et al. 2011). In 
response, community pharmacy has been promoted as needing to have a greater role 
in management of therapeutic drugs (Zermansky 1996), which is reflected in policy 
around service digitalization and repeat dispensing (Cornford et al. 2014).
8.2.2  Computers in English Primary Care
Development of EPS has been able to exploit a substantial installed base of NHS 
primary care informatics which has emerged from over three decades of initia-
tives in community pharmacies, GP practices and by the agency responsible for 
reimbursing primary care contractors for therapeutic drugs dispensed, NHS 
Prescription Services (Hayes 2008). But despite computerisation efforts in all 
three of these constituencies since the 1980s, it was not until the EPS pro-
gramme in 2002 that a concerted effort was made to digitize the exchange of 
prescription data. Prior to this data flowed between the three main constituen-
cies using hand-written, and more recently, computer-printed, paper prescrip-
tion forms, officially known as the FP10.
Of these constituencies, GP practices have the longest history of computerisa-
tion, stemming back to batch processing experiments in the 1960s and real-time 
computing with a shared primary and acute care electronic patient record in the 
1970s (Hayes 2008). The advent of the personal computer in the 1980s, schemes to 
support the adoption of primary care computing such as the Micros for GPs scheme 
(Project Evaluation Group 1985), and a reorganization that placed emphasis on 
documenting care provision as well as experiments in GP fundholding, led to the 
development of GP practice computing in earnest with many vendors entering the 
market (Brennan 2005; Hayes 2008). The numbers of vendors of GP practice sys-
tems subsequently declined through the 1990s, following the imposition of manda-
tory accreditation, but adoption of computerisation increased, reaching 96% of GP 
practices by 1996 (Hayes 2008).
Adoption of these systems by GP practices was initially driven by the value that 
the systems held for these businesses in the face of contractual change. In commu-
nity pharmacy, computerisation was also driven by business concerns. In the 1980s 
pharmacy wholesalers recognized the opportunity for computers to support 
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pharmacists in managing stock, and themselves in supporting ordering. These early 
systems, initially promoted and supplied by wholesalers, were subsequently devel-
oped as a platform that could integrate new clinical functionality. Thus as new pro-
fessional requirements, such as maintaining patient medication records (PMRs) and 
creation of printed labels for dispensed items, came into force, these software sys-
tems were adapted (Shepherd 2008).
Given that it was the business opportunities provided by computers that drove the 
adoption of informatics by primary care providers, it would have been surprising if 
NHS Prescription Services (NHS PS) had failed also to adopt new informatics in sup-
port of its role of remuneration for prescription drugs dispensed. Although some pre-
scriptions do attract a fixed patient co-payment (currently £8.20 ≈ €10.00 per prescribed 
item), the majority of funding for primary care dispensing is from the NHS, and is 
managed by NHS PS. Pharmacies make claims for the costs of dispensing therapeutic 
drugs to NHS PS using the prescriptions they have dispensed. Thus a prescription rep-
resents an invoice to be checked and paid as well as an authorisation to supply thera-
peutic drugs. It also provides a means to capture data on prescribing practices, and to 
collate data that can show how prescribers and GP practices are prescribing in compari-
son to their local and national peers (NHS Prescription Services 2011b, 2012).
NHS PS started computerisation in the 1970s as it became apparent there were 
no longer sufficient numbers of recruits to support the paper intensive process 
(Shepherd 2008). A later automation initiative, the Capacity Improvement 
Programme (CIP) launched in 2007 during EPS development, was similarly a 
response to concerns over the year-on-year prescription volume increases (NHS 
Prescription Services 2008, 2011a). The CIP was however still focused on the paper 
based system, using sophisticated optical character recognition to render prescrip-
tion forms into digital data for processing.
8.2.3  Early ETP Experiments and Pilots
Computerisation of the NHS in the 1980 and 1990s inspired two in-vivo ETP exper-
iments prior to the development of EPS. The first of these was the NHS Care Card 
programme of the late 1980s, which used the then novel technology of microproces-
sor based smartcards held by patients to transfer health record and prescription data 
between suitably equipped health care providers (NHS Management Executive 
1991). Although this experiment, run in parts of England and Wales, did success-
fully demonstrate the service’s concept, concerns over the cost and durability of the 
smartcards, and also of the lack of a back-up network to transfer data in case of 
smartcard failure, led to the abandonment of this solution (Hayes 2008; NHS 
Management Executive 1991).
At the turn of this century, ETP was revisited with a second NHS experiment 
using the new technology of electronic data interchange (EDI) and web services. 
The ETP Pilot Programme of 2000 invited private sector consortia to set up regional 
pilot projects in order to support the development of a set of standards that could 
underpin an England-wide ETP service (NHS Prescription Pricing Authority 2000). 
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From the start it was proposed that the outcomes of the ETP Pilot Programme would 
be reflected in a new ETP service that would be deployed in English primary care 
by 2004, although this timetable was later revised to 2008 as it became apparent that 
the institutional texture of the primary care environment was more complex than 
imagined. Some suppliers in the pilot believed that this could also provide an oppor-
tunity for at scale deployment of their pilot service, but the ETP Pilot Programme 
closed in 2003, as originally envisaged (Mathieson 2003).
The conclusions drawn were that the solutions developed were unable to meet 
stated institutional requirements around ensuring continuity of existing business 
flows between GP practices and community pharmacies (Department of Health 
2004; Sugden 2003). More importantly, the pilot systems were incompatible with 
the new NPfIT vision of service integration, national systems, and shared resources 
(Brennan 2005). However, the vision of ETP as an EDI and network-based service 
remained and influenced the subsequent EPS.
8.3  Assembling the Electronic Prescription Service
EPS at its simplest just offers more reliable data transfer between the three main 
stakeholders using a digital version of the existing FP10 prescription form. Still, 
the influence of EPS inevitably leads to practice change across these institutional 
settings. Claims made for consequential change were often expressed as benefits 
to be realized and illustrate the service’s expected influence on practice. 
Anticipated benefits included support for faster, more efficient prescription pro-
cessing, reduced risk through elimination of transcription errors and the availabil-
ity of electronic cancellation, reduced clinician prescription management 
workload, and increased patient convenience. Another suggested benefit, which 
was not pursued, was the expectation that the service could provide a proxy record 
of patient adherence to treatment through a record of dispensing events (Harvey 
et al. 2014). Concurrent changes in prescription management (discussed below) 
would later bring repeat dispensing prescriptions into the dialectic around EPS, 
and became more dominant as managers and policy makers became familiar with 
the possibilities this could offer (Cornford et al. 2014).
8.3.1  Transforming the Prescription
The benefits of EPS follow from one principal goal, replacing the paper form – known 
in the NHS as an FP10 – as the legal prescription by an electronic and digitally- signed 
equivalent. This form has traditionally been handed from prescriber to patient to dis-
penser and then passed onto NHS PS for reimbursement. Over the years, the FP10 has 
evolved to encompass a number of different functions for prescription management. 
The example shown below (Fig. 8.3) is for a repeat prescription. The left hand side 
represents the prescription which is dispensed against and will be used by the 
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dispenser to claim for what has been dispensed. The right hand side of the FP10 is a 
tear-off reorder form for use by the patient. Re-ordering is allowed for a set number of 
times until a review date has been reached, without the need for a GP consultation on 
each occasion. The right hand side also can be used by the GP practice for health 
promotion messages, or to advertise services, such as flu vaccination, which GP prac-
tices and community pharmacies might compete to provide. The back of the form (not 
shown) includes a signed declaration for those claiming free prescriptions.
Development of the EPS coincided with changes in how prescriptions can be man-
aged. Prior to 2015 prescribers issued either acute or repeat prescriptions (Table 8.1). 
However, concerns over the capacity of GP practices to effectively monitor repeat 
prescriptions (Zermansky 1996) led to a new model of prescription management, the 
repeat dispensing prescription, where the activities of monitoring and control of pre-
scriptions for chronic illness were handed to community pharmacy. This in turn trig-
gered calls for change in the institutional relationship between prescribers and 
dispensers, principally around giving dispensers access to the concurrently developed 
national electronic Summary Care Record (SCR).
Fig. 8.3 English primary care FP10 prescription form (Gooch 2007a, b). Copyright © 2016, 
Re-used with the permission of the Health and Social Care Information Centre, also known as 
NHS Digital. All rights reserved.
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8.3.2  Architecture
As a part of the NPfIT portfolio of projects EPS was explicitly designed alongside 
efforts to build services that met agreed national informatics standards. NPfIT was 
based on commitment to a common infrastructure through which constituent com-
ponents such as EPS, SCR, the Care Records Service and others could connect and 
exchange data. At the core of this was a data-center and communications backbone, 
known as the Spine, providing common services and enabling the transfer of data 
between NHS computer systems. NPfIT also established a national secure network 
for the NHS – known as N3. The services used by EPS included the N3 network, 
extended to include links to high street pharmacies, and two principle Spine Services 
to manage the delivery of prescriptions: an Identity Agent service to establish the 
validity of prescribing and dispensing endpoints, and the NHS Smartcard to imple-
ment role based access control for prescribers and dispensers (Fig. 8.4). In addition 
a new underlying drug dictionary (dm+d) was developed – described below.
EPS functionality for prescribing and dispensing would however be delivered to 
health professionals by the vendors of community pharmacy and GP practice soft-
ware, and to do so would make use of these core infrastructures and central data 
Table 8.1 Types of Prescription Used in English Primary Care (Cornford et al. 2014)
Type Application Management
Acute 
prescription
A one-off prescription for short term 
illness issued following a consultation 
between patient and general practitioner 
(GP)
The prescription is presented to the 
community pharmacist. Clinical 
checks are conducted by the 
pharmacist to ensure the 
prescription is appropriate for the 
patient. If the prescription is 
appropriate the relevant drugs are 
dispensed to the patient
Repeat 
prescription
Prescription is issued for the 
management of a long-term condition 
following a consultation between patient 
and GP. It is agreed by both parties that 
the prescription can be re-issued a set 
number of times until a review date 
without further consultations
Prescription is presented to the 
community pharmacist and checked 
and dispensed against as for acute 
prescriptions. The prescription is 
re-ordered from the GP practice 
using an order form printed with the 
prescription, and will be re-issued 
unless a review date has been 
reached or there are concerns over 
patient adherence
Repeat 
dispensing 
(introduced 
2005)
Prescription is also used for long-term 
condition management. All issues of a 
prescription that the patient is expected to 
need until the review date are issued as a 
single batch. On paper these prescriptions 
are sent to a single pharmacy. With the use 
of electronic prescriptions each issue is a 
separate entity that can be dispensed 
against at any pharmacy
A batch of prescriptions is handed 
to the community pharmacist. Each 
issue is dispensed against when 
requested by the patient. 
Prescriptions are dispensed against 
in the same manner as an acute 
prescription with the addition of a 
check by the community pharmacist 
of patient’s use of the medicine
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services. A set of output-based specifications were made available to software ven-
dors that described how the EPS software for doctors and pharmacists should man-
age and process electronic prescriptions (Gooch 2007a, b). Compliance of software 
with these specifications was assessed through a multi-stage common assurance 
process (CAP) managed centrally (NHS Connecting for Health 2012). These speci-
fications provided a partial definition of the operation of the service, but details as 
to the management of user interfaces and circumstances for the creation of paper 
versions of the electronic prescriptions was placed in system suppliers’ hands.
Electronic Drug Dictionaries
Prior to EPS there was no single database of therapeutic drugs available for 
use within GP practice systems, system vendors choosing from a number of 
commercial suppliers, such as First Databank Europe, or opting to develop 
their own, as EMIS, a major software supplier, did. In parallel NHS 
Prescription Services compiled a monthly Drug Tariff based on manufacturer 
data, marketing authorisations, and latterly, dispensing volumes. One conse-
quence of EPS was that a new and common underlying database to describe 
medicines as they were prescribed, dispensed and paid for was developed, the 
dictionary of medicines and devices (dm+d). This ontology can represent 
therapeutic drugs at multiple levels depending on how the data was to be 
used. To support access to existing decision support systems manufacturers 
might chose to map dm+d coding to their own dictionaries, which also allows 
the development of decision support across multiple international markets
Fig. 8.4 Components of the electronic prescription service (Health and Social Care Information 
Centre n.d.). Copyright © 2016, Re-used with the permission of the Health and Social Care 
Information Centre, also known as NHS Digital. All rights reserved. 
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8.3.3  Release Strategy and Deployment
EPS was structured and delivered to users as two sequential releases. The releases 
differed in their functionality and the demands made on dispensing and prescribing 
health professionals. This approach allowed for tests of the technical infrastructure 
to be conducted in the first release, including networking and the Spine services 
developed for NPfIT (Brennan 2005).
EPS Release 1 (EPS R1) focussed on augmenting the paper prescription with 
digital data (Fig. 8.5). A unique identifier for each prescription was created at 
the time of prescribing and printed on the prescription as a barcode. A digital 
copy of the prescription was then sent to the Spine. A pharmacy could scan this 
barcode and download a digital copy to be used to populate the patient medica-
tion record (PMR) in the pharmacy system and help in stock control and label 
creation. Although a dispenser could forward the digital version of the prescrip-
tions to NHS Prescription Services, this functionality simply served as a test of 
prescription transmission with no immediate benefit for community phar-
macy. In many ways EPS R1 was a partial parallel run of digital and paper 
systems side by side from which much was learned about the network and the 
software.
EPS release 2 (EPS R2) expanded the administrative and clinical functionality 
and enabled electronic and paper artefacts to trade legal status (Fig. 8.6). In EPS R2 
the digital message has the legal status as a prescription, and is dispensed against 
and used to claim for remuneration. In addition, new clinical functionality in the 
form of repeat dispensing prescriptions and safety functions, such as electronic can-
cellation of prescriptions were added, with the expectation of more timely and 
effective delivery of prescription drugs to patients as well as efficiency benefits for 
GPs, pharmacists and NHS PS.
At the time that EPS R2 was ready to be deployed NHS primary care was com-
posed of a number, of local health authorities, known as Primary Care Trusts (PCTs). 
In order to issue digitally signed electronic prescriptions, the PCT had to have 
Secretary of State Directions (e.g. permission). This was issued based on the readi-
ness of the PCT to manage the local deployment process. Control over which pre-
scribers could issue electronic prescriptions was at the discretion of the PCT. A GP 
practice would only be allowed to use EPS R2 when at least 80% of their existing 
prescription volumes could be sent to dispensing sites that had EPS available. This 
ensured both that there were local places to send prescriptions to, and helped avoid 
market distortion.
However, whilst a prescriber might be authorised to issue electronic prescrip-
tions, not everything prescribed could be sent electronically, specifically certain 
schedules of controlled drugs –drugs that can be abused or employed for nefarious 
purposes (Department of Health 2014). Following a high profile case of murders 
committed using diverted controlled drugs, the department responsible for drugs 
policy, the Home Office, revised the Misuse of Drugs Act to restrict the 
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Medicines Supply Event Artefacts and Data Flows
Prescriber (Pr.) creates paper prescription (PP) which
is handed to the patient (Pa.). An electronic copy of 
the prescription (EC) is sent to the Spine (Sp.).
Patient attends the community pharmacy (Ph.). The
pharmacy team can retrieve the electronic copy of the
prescription by scanning the barcode on the paper 
prescription. The barcode contains the unique 
identifier (UI) associated with the paper prescription. 
The UI is sent to the Spine which will relay to the 
pharmacy the appropriate electronic copy of the
prescription for download.
Prescription items are assembled and dispensed to
the patient using the paper prescription.
If required, the community pharmacist hands the
patient the paper prescription for the patient to make
any declarations.
The paper prescription is handed back to th
pharmacist when relevant declarations, if required,
have been noted by the patient.
Community pharmacist adds endorsements to the
paper prescription to show what dispensed and to
indicate where additional fees claimed.
Community pharmacist collects dispensed 
prescriptions together and sorts these. The paper 
prescriptions are sent as a batch to NHS Prescription
Services, the reimbursement agency (Re.) for primary
care, by the monthly deadline.
Electronic copy of the dispensed paper prescription
can be sent to NHS Prescription Services via the
Spine as a test of system operation.
8
7
6
5
4
3
2
1
Pa.
PP
PP
PP
PP
PP
PP
PP
EC EC
UI
EC
EC
Pr. Ph. Sp. Re.
Fig. 8.5 Operation of the electronic prescription service release 1
opportunities for diversion. So, despite the potential that EPS had in restricting and 
auditing supply, it was not until July 2015, that the Misuse of Drugs Act and other 
regulations were amended to allow for full electronic prescribing of controlled 
drugs (Department of Health 2015).
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Fig. 8.6 Operation of the electronic prescription service release 2
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8.4  Assembling EPS as Past, Present and Future
In this section we consider the nature of the work needed to assemble the EPS we 
see today. We do this using a model that identifies the work of assembly in terms 
of constraints imposed within the context of EPS development and deployment, 
inertia resulting from unaligned incentives and lack of resources, and finally con-
cern to maintain fidelity to the mission of the broader NHS, its culture and practices 
(Fig. 8.1).
8.4.1  The Physical and Material in a Digital World
We start by considering EPS in its technical/architectural form employing a range 
of digital services to support communication of relationships about the physical 
world in terms of medicines, people and locations. General communication stan-
dards introduced across the NHS by NPfIT such as ebXML, HL7 and the clinical 
coding terminology SNOMED CT, provide underlying substrates for this commu-
nication. Other specific new services were developed, for example, electronic veri-
fication of users and sites by Spine Identity Agent which check both validity of 
role-profiles on individuals’ Smartcard and the identity of endpoints through 
Organisational Data Services (ODS) codes. As noted above, the therapeutic drugs 
that can be prescribed using EPS are described in a new electronic dictionary of 
medicines and devices (dm+d) developed for EPS.
These protocols, databases and services each fulfill necessary roles and functions 
in the new EPS, but EPS must also show some fidelity to established structures, 
practices and professional roles within the NHS. A primary example is the FP10 
prescription form. The FP10 endures within EPS in many ways and links it to the 
past and facilitates its viability in the present. The continuing presence of the FP10 
within EPS is in part a means of overcoming inertia and institutional constraints in 
implementation and also a demonstration of fidelity with the past. Retaining ele-
ments of the FP10 in the assembly ensures a better ‘fit’ of the new EPS in the wider 
health care context, both conceptually and practically. The FP10 also endures in a 
printed form, although without legal status. For example, a printout may support the 
FP10’s traditional role in collecting patients’ signed declarations for prescription 
charge exemptions as well as meeting dispensers’ needs for a portable representa-
tion of the prescription, a picking list, against which to assemble drugs when dis-
pensing. Similarly, a prescriber may wish to give a patient a paper copy of their 
drugs to keep, even if the prescription itself is electronically transmitted. And we 
know that ‘handing over the prescription’ is a common way that doctors politely 
terminate a consultation.
In the new electronic world, just as with paper prescribing, an EPS prescription can 
be composed of multiple prescription messages, each message constrained to a maxi-
mum of four prescription items. This constraint, originally imposed by the physical 
size of the FP10 form, endures in EPS reflecting the need to replicate existing FP10 
processes, for example in its role as a dispenser’s picking list. This fidelity is 
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reinforced by the inertia implied in the delivery model used for EPS, in which provid-
ers of existing prescribing and dispensing software were invited to integrate relevant 
functionality into their existing software systems. As a result many aspects of EPS 
software design, in particular interfaces, drew directly on existing processes for FP10 
handling in GP practices, Community Pharmacies and NHS Prescription Services.
8.4.2  The Reinvention of Services
EPS is constrained and shaped by the complex and multiple institutional and technical 
relations in which it is embedded. The confluence of multiple institutional presents 
place constraints on how and what EPS can do or change, and can conspire to reduce 
the service functionality and availability. These constraints invite resolution over time 
through such things as regulatory change (e.g. controlled rugs), workarounds and re-
purposing of infrastructures. Indeed, work-arounds are a common and an essential 
part of EPS’s ability to respond to challenges and reshape itself over time.
This is also seen in the ways that the NHS Smartcard is repeatedly renegotiated 
as a part of EPS. The NHS Smartcard implements a Role Based Access Control 
(RBAC) model in which access to services are associated with specific privileges 
for individual’s roles stored in the Spine’s Identity Agent (NHS Connecting for 
Health 2011). A health professional’s NHS Smartcard has to be in an attached reader 
for the session and a password entered at the start of a session. This is broadly suit-
able to work practices of prescribers in primary care and such use, for example by 
doctors preparing prescriptions, predates EPS.
This model was not, however, found appropriate for dispensers in community 
pharmacy and indeed was never designed to encompass ‘non NHS’ persons in pri-
vate organisations – the status of a community pharmacist, either as a permanent or 
locum staff. The result is that new models of Smartcard use emerged in the form of 
work-arounds. First, for EPS R1, given access is only to an electronic copy of the 
patient’s prescription, information that the community pharmacy already has, the 
solution found was simple. Each community pharmacy was issued with an NHS 
Smartcard that acted as a proxy for the site, and which represented shared rather 
than a personal roles and privileges. But this ‘fix’ could not work in EPS R2 where 
dispensers gained access to Spine services that support inspection and amendment 
of patient data, which requires an audit trail (NHS Connecting for Health 2010).
For EPS R2, community pharmacies moved to the model used by NHS clini-
cians. In this model the Spine Identity Agent records the identity of the clinician, the 
clinician’s roles and the sites at which this role is enacted, each site being identified 
by an ODS code. Locum community pharmacists, moving often from site to site, 
posed a problem if their ODS mapping requires frequent updates. The solution 
found was to create a virtual organisation for dispensing staff, initially community 
pharmacists but later dispensing technicians too, which was given the ODS code 
FFFFF, the 5-F code (NHS Connecting for Health 2010). This workaround allowed 
an EPS R2 user access to limited patient data. However, it is now policy that phar-
macists have access to the Summary Care Record (SCR) – a national summary of 
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the individual health record including medicines prescribed, seen as an essential 
tool to support pharmacists in safe therapeutic drug supply. This created a need to 
reinvent the process once again to provide a more detailed audit trail. Now locum 
staff access the SCR by the ‘emergency’ access button plus manually inputting the 
ODS code for the site where they are working (Royal Pharmaceutical Society 2014).
8.4.3  Ruthless Standardization
We will improve the leadership and direction given to IT, and combine it with national and 
local implementation that are based on ruthless standardisation. (Department of Health 
2002)
NPfIT, the large national programme within which EPS was initiated, started out 
with a mantra of ‘ruthless standardization’. It took time to dilute and finally wash 
this idea away. EPS as it has been delivered is very much a child of this policy and 
the retreat from it. Initially NPfIT proposed that all GP systems would be replaced 
with just one of two national ‘solutions’ incorporating EPS. In time there was revolt 
as GPs realised they would be coerced into giving up systems they knew and trusted. 
To placate them, in 2006 a new model of GP software procurement was established, 
GP Systems of Choice (GPSoC). This allowed GP practices theoretically to adopt 
any software that offered GPSoC functionality including EPS and the Summary 
Care Record (NHS Connecting for Health 2008).
The GPSoC model of approval based around output-based specifications (OBS) 
only defined how electronic messages would be handled. So controlled drugs initially 
fell outside of EPS and thus also fell outside of the OBS. Consequently, with no guid-
ance available as to how to manage prescriptions which contained both EPS and non-
EPS items, no common model was proposed for managing these situations. Some 
software suppliers choose to prevent any part of a prescription containing controlled 
drugs being transmitted electronically, others choose to create an electronic prescrip-
tion for non-controlled drugs, and in parallel a paper prescription for the out-of-scope 
controlled drugs. Receiving drugs from GP practices with systems adopting the latter 
model caused confusion and inconvenience in their own work practices and for 
patients. This was only resolved when the law on controlled dugs changed.
A more active approach to addressing inertia and limited resources is seen in the 
structuring of development of pharmacy systems and the lengthy period of software 
testing required by the Common Assurance Process (NHS Connecting for Health 
2008). This stepped assurance process for both dispensing and prescribing systems, 
moved from safety case analysis through to in-vitro testing with test messages in a 
sandpit environment through to in-vivo testing in a limited number of sites with a 
test set of messages, and later, real prescriptions. This detailed programme provided 
a mechanism through which to focus resources and supplier attention. Deliberate 
selection of early implementation sites on the basis of their readiness also allowed 
for the gradual expansion of the service and provided some quarantine for problems 
arising and unexpected events.
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8.5  What Can the Electronic Prescription Service Teach Us?
Looking back over the history of EPS, what stands out is how much of EPS is 
formed by hybridisation of the digital and the physical/material. EPS was conceived 
to be new and powerful, embodying policy visions of transformation, but it had also 
to fit within existing processes and work practices, mimicking existing data flows, 
and co-opting core artefacts such as the FP10. Thus a flexible and evolving assem-
bly of the digital and the physical was necessary for EPS to come into existence. 
Further, it is from the institutional environment as much as the installed base of 
infrastructures that the necessary conditions and resources for EPS are mobilised, 
assembled and sustained. Of course in this they also create (assemble) the condi-
tions for complications, as we saw with regard to management of prescriptions for 
controlled drugs in the early implementation of EPS and the multiple reconfigura-
tions of the NHS smartcard RBAC system.
EPS also illustrates how inertia, as represented in the limited capacities of dis-
pensing and prescribing system suppliers to resource change, can be managed 
through institutional arrangements such as testing and controlled deployment. 
NPfIT and those managing the deployment used the power to establish specific 
arrangements to overcome inertia and channel limited resources within the supply 
network and in the context of use. Even a programme with unprecedented political 
commitment behind it, as NPfIT had at the outset, had to remain flexible. So our 
final message drawn form EPS is that the search for new opportunities within and 
beyond the installed base is driven by a creative search across institutional spaces as 
much if not more than across technological spaces. The installed base is in this way 
more diverse, and more pliable than we might at first think, and introduction of 
innovation rests on the opportunities and routes carved through.
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